CLINICAL TRIALS
Three times a year we update our overview of clinical trials in PNH taking place in each country. For the latest information on clinical trials you may want to go to the source of our overview which can be found here.
- ADARx Pharmaceuticals – ADX-038-101
- Akari – AK585 CONSENT II
- Alexion – ACH228-110
- Alexion – ALXN2040-PNH-301 ALPHA
- Alexion – ALXN2040-PNH-303
- Alexion – D7414C00001
- Apellis – APL2-307
- Apellis – APL2-PNH-209
- BioCryst – BCX10013-105
- BioCryst – BCX9930-201
- BioCryst – BCX9930-203 REDEEM-1
- BioCryst – BCX9930-203 REDEEM-2
- BioCryst – BCX9930-205 2021-006776-17
- Care Pharma – CAN 106-PNH- 102/201
- City of Hope – 1089 P30CA033572
- Fred Hutchinson Cancer Center – BMTCTN1904
- Kira pharmaceuticals – KP104-201
- Medicine Co. – HRS-5965-202
- NHLBI – 100154 0154
- NHLBI – 180090 18-h-0090
- Novartis – CLNP023C12001B
- Novartis – CLNP023C12303
- NovelMed – NM8074
- NovelMed – NM8074
- NovelMed – NM8074-PNH-101
- Omeros – OMS906-PNH-002
- Omeros – OMSS906-PNH-001
- Regeneron – 2050 2021-004931-10
- Regeneron – R3918-PNH-2021 2050 2021- ACCESS-1
- Roche – BO42161 COMMODORE 1
- Roche – BO42162 COMMODORE 2
- Roche – BP39144 COMPOSER
- Roche – YO42311 COMMODORE 3
- Roswell – I 40916 NCI-2017-01949
- Wuhan createrna science – MY008211A- PNH-2-01
- Wuhan createrna science – MY008211A- PNH-2-01-F